Skip to main content

Table 2 Study A; Number of Patients with Treatment-Related Toxicities and Study B; Number of Patients with Treatment-Related Toxicities

From: Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

A

  

Toxicities

Grade 3 or 4

Grade 5

Study A

  

Hemorrhagic stroke

-

1

Pain

2

-

Fatigue

1

-

Constipation

1

-

Anorexia

1

-

Deep vein thrombosis

1

-

B

Study B

Grade 2

Grade 3 or 4

Neutropenia

2

-

Hyponatremia

-

1

Diarrhea

-

1

Fatigue

-

1

Hyperglycemia

-

1

Mucositis

2

-

Pneumonia

2

-

Dehydration

2

-

Nausea

2

-

Rash

2

-

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us